A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Lipid nanoparticle (LNP) technology for mRNA delivery
U.S. Patent No. 11,246,933 Issued: February 2022Assignee: Typically assigned to parties controlling foundational LNP technology asserted against Pfizer, BioNTech, and Moderna (e.g., Alnylam’s biomaterial patents)Focus: Biodegradable cationic lipid compositions and related LNP delivery technology used for delivering…
-
Pharmaceutical Composition of S‑Ketamine Hydrochloride
U.S. Patent No. 11,446,260 B2 Assignee: Janssen Pharmaceuticals, Inc. (a J&J subsidiary)Issued: September 20, 2022Focus: A pharmaceutical composition of S‑ketamine hydrochloride formulated for intranasal administration without an added antimicrobial preservative — a formulation forming the core of J&J’s SPRAVATO®…
-
Expression of Regeneration Factors in Aged/Senescent Cells
International Application: WO2023075374A1 (filed 2023/09/28)Assignee: Altos Labs, Inc.Title: Expression of regeneration factors in aged/senescent cellsStatus: Published in April 2024 but tied to a 2022–2023 filing cycleFocus: Partial cellular reprogramming compositions and methods aimed at rejuvenating aged or…
BioTech IP Review 